VHCP Management III as of Sept. 30, 2019
Portfolio Holdings for VHCP Management III
VHCP Management III holds 17 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals (MIST) | 23.8 | $39M | 2.1M | 18.65 | |
| Axsome Therapeutics (AXSM) | 20.1 | $33M | 1.6M | 20.24 | |
| Ra Pharmaceuticals | 9.8 | $16M | 670k | 23.65 | |
| 10x Genomics Inc Cl A (TXG) | 9.3 | $15M | 300k | 50.40 | |
| Protagonist Therapeutics (PTGX) | 8.0 | $13M | 1.1M | 12.01 | |
| La Jolla Pharmaceuticl Com Par | 6.8 | $11M | 1.3M | 8.80 | |
| Obseva Sa | 6.0 | $9.7M | 1.2M | 8.33 | |
| BioCryst Pharmaceuticals (BCRX) | 4.8 | $7.7M | 2.7M | 2.86 | |
| Kalvista Pharmaceuticals (KALV) | 4.6 | $7.4M | 638k | 11.60 | |
| Marinus Pharmaceuticals | 2.4 | $3.9M | 2.5M | 1.54 | |
| Tricida | 1.5 | $2.5M | 80k | 30.87 | |
| Kiniksa Pharmaceuticals | 1.5 | $2.4M | 277k | 8.51 | |
| Bellerophon Therapeutics | 0.7 | $1.2M | 2.4M | 0.48 | |
| Radius Health | 0.4 | $596k | 23k | 25.77 | |
| Constellation Pharmceticls I | 0.3 | $431k | 67k | 6.46 | |
| Proteostasis Therapeutics In | 0.1 | $188k | 221k | 0.85 | |
| Prevail Therapeutics Ord | 0.0 | $54k | 4.4k | 12.25 |
